4/A: Zomedica Director Jeffrey M. Rowe Amends Form 4 to Correctly Report Share Ownership

Jeffrey M. Rowe, a director of Zomedica Corp., amended his Form 4 filing to accurately reflect share ownership held by the Jeffrey M. Rowe Living Trust.

Summary

• Jeffrey M. Rowe, a director of Zomedica Corp., filed an amended Form 4 with the SEC.
• The amendment corrects the total number of shares held by the Jeffrey M. Rowe Living Trust.
• The original Form 4 incorrectly reported that Mr. Rowe held 275,000 shares in his individual capacity.
• The corrected filing shows the Jeffrey M. Rowe Living Trust as the holder of these shares.
• On March 17, 2025, the Jeffrey M. Rowe Living Trust acquired shares of common stock through multiple transactions at prices ranging from $0.064 to $0.071.
• Following these transactions, the Jeffrey M. Rowe Living Trust beneficially owns 2,378,485 shares.
• Additionally, 11,120,000 shares are held by Rowe Family GST and 181,000 shares are held by IRA.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing correcting a previous error. It doesn't inherently indicate positive or negative sentiment, but accuracy in reporting is generally viewed favorably.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, ensuring transparency and compliance with SEC regulations.

Stakeholder Impact

• The correction of share ownership information ensures transparency for shareholders.

Key Dates

Keywords

Form 4, Zomedica, Share Ownership, Jeffrey M. Rowe, Amendment, Director